Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly out-of-pocket price cap, which is set by law.
Although California's governor hoped to have the cheaper insulin available by last year, it may take at least another two years.
And it's important because going forward, we've gotten used to have very cheap generics and insulin and other biologics are not as cheap to manufacture and they're not as easy to do that kind of ...
Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type ...
Subscribe to CalMatters today for nonprofit news in your inbox. Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the ...